Page last updated: 2024-11-01

nimodipine and Pain, Intractable

nimodipine has been researched along with Pain, Intractable in 2 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Pain, Intractable: Persistent pain that is refractory to some or all forms of treatment.

Research Excerpts

ExcerptRelevanceReference
"Nimodipine was withdrawn in 5 patients during the first week of treatment due to intolerance (n = 3) or aggravation of the disease (n = 2)."2.67Enhancement of opiate analgesia by nimodipine in cancer patients chronically treated with morphine: a preliminary report. ( Flórez, J; Hurlé, MA; Maestre, JM; Santillán, R, 1994)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Santillán, R2
Maestre, JM1
Hurlé, MA2
Flórez, J2
Armijo, JA1
de los Mozos, R1

Trials

2 trials available for nimodipine and Pain, Intractable

ArticleYear
Enhancement of opiate analgesia by nimodipine in cancer patients chronically treated with morphine: a preliminary report.
    Pain, 1994, Volume: 58, Issue:1

    Topics: Administration, Oral; Adult; Aged; Analgesia; Drug Synergism; Drug Tolerance; Female; Humans; Inject

1994
Nimodipine-enhanced opiate analgesia in cancer patients requiring morphine dose escalation: a double-blind, placebo-controlled study.
    Pain, 1998, Volume: 76, Issue:1-2

    Topics: Aged; Analgesics, Opioid; Biotransformation; Calcium Channel Blockers; Double-Blind Method; Drug Syn

1998